NITROFURANTOIN 100 MG
NITROFURANTOIN : 100 MG · DIN 00312738 · AA PHARMA INC
Health Canada status: MARKETED
What is NITROFURANTOIN?
NITROFURANTOIN 100 MG contains NITROFURANTOIN : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00312738, held by AA PHARMA INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 25-Oct-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NITROFURANTOIN used for?
Treatment of pyelonephritis, pyelitis, and cystitis when due to susceptible organisms. Not for renal cortical/perinephric abscesses or prostatitis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00312738 |
|---|---|
| Brand name | NITROFURANTOIN |
| Generic / active ingredient | NITROFURANTOIN : 100 MG |
| Manufacturer | AA PHARMA INC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01XE01 NITROFURANTOIN |
| AHFS class | 08:36.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 25-Oct-2011 |
| Original market date | 1974-12-31 00:00:00 |
How is it administered?
Adults: 50 to 100 mg four times a day for at least 1 week. Administer with food or milk to minimize gastric upset.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at temperature not exceeding 25°C. Protect from light.
How is it supplied?
Bottles of 100 tablets.
Contraindications
Hypersensitivity; anuria, oliguria, or renal impairment (CrCl < 40 mL/min); pregnant patients at term; infants under 1 month of age.
Warnings and precautions
May cause fatal peripheral neuropathy; discontinue if numbness occurs. May cause hemolytic anemia (G6PD deficiency). Pulmonary reactions (acute or chronic) may occur. May cause dizziness.
What can be used instead?
Other Canadian products sharing ATC code J01XE01 NITROFURANTOIN. 9 of 24 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-NITROFURANTOIN BID | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02466392 |
| JAMP NITROFURANTOIN | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02495511 |
| JAMP NITROFURANTOIN | 50 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02495503 |
| JAMP NITROFURANTOIN BID | 100 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | DIN 02544954 |
| NITROFURANTOIN | 50 MG | TABLET | AA PHARMA INC | MARKETED | DIN 00319511 |
| PMS-NITROFURANTOIN BID | 100 MG | CAPSULE | PHARMASCIENCE INC | MARKETED | DIN 02455676 |
| TEVA-NITROFURANTOIN | 100 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02231016 |
| TEVA-NITROFURANTOIN | 50 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | DIN 02231015 |
| MACROBID | 100 MG | CAPSULE | ALLERGAN INC | CANCELLED POST MARKET | DIN 02063662 |
| MACRODANTIN | 25 MG | CAPSULE | ALZA CORPORATION | CANCELLED POST MARKET | DIN 01997599 |
Who else supplies NITROFURANTOIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NITROFURANTOIN appears in 46 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.